Analytical Data
-
Gene name
BMP-4
- Application
-
Alternative Names
BMP2B; BMP2-B; BMP2B1; ZYME; DVR4; Bone morphogenetic protein 2B
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 97% as determined by SDS-PAGE.
-
Uniprot
P12644
-
Expression Region
Ser293~Arg408
-
Protein Length
Partial
-
Molecular Weight
15kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Related Products
Protein Description
Bone Morphogenetic Protein 4 (BMP-4) is a member of the transforming growth factor-beta (TGF-β) superfamily, known for its crucial role in regulating embryonic development, particularly in bone and cartilage formation. Research on BMP-4 has gained momentum due to its significant implications in various biological processes, including mesenchymal stem cell differentiation, tissue regeneration, and repair, as well as its involvement in pathological conditions like cancer and degenerative diseases. BMP-4 functions primarily through activating specific receptors on target cells, leading to a cascade of intracellular signaling pathways that influence gene expression. The recombinant production of BMP-4 has facilitated extensive studies aimed at understanding its mechanism of action and therapeutic potential. Researchers have developed various recombinant forms of BMP-4, enabling investigations into its precise effects on skeletal tissues and its utility in clinical applications, such as enhancing bone healing in orthopedic surgeries and treating bone-related disorders. Furthermore, studies have delved into the molecular interactions of BMP-4 with other signaling pathways, underscoring its role in a complex network of growth factors. Overall, the ongoing exploration of BMP-4, particularly its recombinant protein forms, continues to shed light on its biological significance and pave the way for innovative therapeutic strategies in regenerative medicine.
